Active, not recruitingInterventionalNot ApplicableUpdated May 9, 2025
Evaluation of the Timing of the Nebulization Related to the Physiotherapy Session | NCT02201082 | Trialant
CompletedInterventionalNot ApplicableUpdated Aug 25, 2015
Evaluation of the Timing of the Nebulization Related to the Physiotherapy Session
ClinicalTrials.gov ID
NCT02201082
Lead Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
15Actual
Last Update Posted
Aug 25, 2015Estimated
Start Date
Sep 2012
Primary Completion Date
Jul 2013Actual
Completion Date
Jul 2015Actual
Brief Summary
The purpose of this study is to determine the optimal time for the nebulization depending on the respiratory physiotherapy session in cystic fibrosis patients.
Cystic Fibrosis
Airway clearance technique
Amikacin nebulization
Ages Eligible for Study
Child (0-17)Adult (18-64)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Stable cystic fibrosis patients older than 16 y.o.
Pseudomonas aeruginosa colonization
Hypersecretion
Exclusion Criteria:
Kidney failure
No pregnancy
Primary Purpose
Treatment
Allocation
Randomized
Interventional Model
Parallel Assignment
Masking
Single
No central contacts
There are no central contacts for this study.
Cliniques universitaires Saint-Luc
Brussels, 1200, Belgium
Lead Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER